Analysts think RANI stock price could increase by 1635%
Aug 14, 2025, 11:25 AM
-6.33%
What does RANI do
Rani Therapeutics Holdings, a clinical-stage biotherapeutics company based in San Jose, California, focuses on developing oral delivery technologies like the RaniPill capsule for biologics and drugs. The company went public on July 30, 2021, and has a pipeline that includes multiple drug candidates.
6 analysts think RANI stock price will increase by 1634.69%. The current median analyst target is $9.18 compared to a current stock price of $0.53. The lowest analysts target is $5.05 and the highest analyst target is $12.60.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
